In a 71-year-old female whose insurance does not cover estradiol patches, what does the abbreviation PTWK (per week) signify, and what is the estradiol PTWK formulation?

What is Estradiol PTWK?

PTWK is a pharmacy abbreviation meaning "per week" (Per The WeeK), indicating that the estradiol formulation is dosed on a weekly basis—most commonly referring to transdermal estradiol patches that are applied once weekly.

Understanding the Abbreviation

The "PTWK" designation on your insurance formulary list refers to weekly-dosed estradiol patches. These are transdermal delivery systems designed to release estradiol continuously over a 7-day period, requiring only once-weekly application rather than twice-weekly changes 1, 2.

Available Weekly Patch Options

For a 71-year-old woman, the typical weekly patches deliver:

• 25 mcg/day (lower dose)
• 50 mcg/day (standard dose)
• 75-100 mcg/day (higher doses)

These patches maintain therapeutic estradiol levels throughout the entire 7-day wearing period, avoiding the peak-trough fluctuations seen with twice-weekly patches 1.

Comparing Your Insurance Options

Given your formulary choices, here's the practical breakdown:

For Systemic Symptoms (Hot Flashes, Night Sweats):

• Estradiol PTWK (weekly patches) would be appropriate
• Oral Premarin (conjugated equine estrogens) is also effective but carries higher thrombotic risk due to first-pass hepatic metabolism

For Vaginal Symptoms Only (Dryness, Dyspareunia, Urinary Issues):

• E-string (vaginal ring) is the preferred low-dose vaginal option—releases 7.5 mcg/day, changed every 3 months, maintains postmenopausal estradiol levels with minimal systemic absorption 3
• Premarin vaginal cream at 0.3 mg doses is also effective for vaginal symptoms 3

Clinical Decision Algorithm

Step 1: Determine if she needs systemic vs. local therapy

• Systemic symptoms (vasomotor, bone protection) → Choose estradiol PTWK patches or oral Premarin
• Vaginal symptoms only → Choose E-string or Premarin vaginal cream

Step 2: If choosing systemic therapy, consider thrombotic risk

• Lower VTE risk preferred (age 71 is relevant here) → Estradiol PTWK patches (transdermal avoids first-pass hepatic effect, lower thrombotic risk than oral) 3
• If patches impractical → Oral Premarin, but acknowledge increased VTE risk

Step 3: If choosing vaginal therapy

• Prefer E-string for convenience (quarterly changes vs. daily/twice-weekly cream application) and consistent low-dose delivery 3
• Premarin vaginal cream requires more frequent application but allows dose flexibility

Important Caveats for Age 71

At 71 years old, several considerations apply:

• If starting hormone therapy for the first time or it's been >10 years since menopause, the WHI data showed increased stroke risk in women >65 years on systemic estrogen 4, 5
• For vaginal symptoms alone, low-dose vaginal estrogen (E-string) is safer than systemic therapy and doesn't carry the same cardiovascular warnings 3
• Weekly patches have better adhesion than twice-weekly formulations, which matters for older skin 2

Practical Recommendation

If she has only vaginal/urinary symptoms: Choose E-string. It's the most convenient (change every 90 days), maintains minimal systemic absorption, and is highly effective for genitourinary symptoms 3.

If she has systemic symptoms requiring hormone replacement: Choose estradiol PTWK patches starting at the lowest effective dose (typically 25-50 mcg/day), as transdermal delivery has a more favorable safety profile than oral estrogen at her age, particularly regarding VTE risk 3.

Avoid oral Premarin if transdermal options are available, given her age and the associated thrombotic risks from first-pass hepatic metabolism.